This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Altria Focuses on Pricing & RRPs Amid Low Cigarette Volumes
by Zacks Equity Research
Altria's (MO) expansion in RRPs and focus on pricing bode well amid declining cigarette shipment volumes.
Philip Morris Battles Low Cigarette Volumes, Pricing Aids
by Zacks Equity Research
Philip Morris' (PM) performance is bearing adverse impacts of declining cigarette sales volume. However, expansion in RRPs and strong pricing are significant upsides.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $51.09, marking a -0.31% move from the previous day.
Altria (MO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $50.22, marking a -0.69% move from the previous day.
Tobacco Industry Outlook Cushioned by RRP Strength & Pricing
by Vrishali Bagree
Regulatory headwinds and growing health consciousness are weighing on cigarette sales. Nevertheless, tobacco players are gaining from efficient pricing and strength in RRPs.
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $49.62, marking a +0.75% move from the previous day.
Should Value Investors Consider Altria Group (MO) Stock Now?
by Zacks Equity Research
Let's see if Altria Group (MO) stock is a good choice for value-oriented investors right now from multiple angles.
Altria (MO) Stock Moves 0.01%: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $50.41, marking a +0.01% move from the previous day.
The Zacks Analyst Blog Highlights: Amazon, Bank of America, Comcast, IBM and Altria
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amazon, Bank of America, Comcast, IBM and Altria
Top Research Reports for Amazon, Bank of America & Comcast
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Amazon (AMZN), Bank of America (BAC) and Comcast (CMCSA).
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $51.37 in the latest trading session, marking a +1.06% move from the prior day.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $49.93, marking a -0.74% move from the previous day.
Altria (MO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $50.43, marking a +0.52% move from the previous day.
The Zacks Analyst Blog Highlights: JPMorgan Chase, Altria, ConocoPhillips, The Travelers Companies and Twitter
by Zacks Equity Research
The Zacks Analyst Blog Highlights: JPMorgan Chase, Altria, ConocoPhillips, The Travelers Companies and Twitter
Top Research Reports for JPMorgan, Altria Group & ConocoPhillips
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Altria Group, Inc. (MO) and ConocoPhillips Company (COP).
Buy Cronos (CRON) Stock Ahead of Earnings as Bet on Marijuana Comeback?
by Benjamin Rains
Should investors think about buying some shares of Cronos (CRON) ahead of earnings, as a bet on a marijuana market comeback?
Philip Morris Trims View on Berlin Plant Closure Charges
by Zacks Equity Research
Charges of almost $355 million related to the closure of Berlin plant compel Philip Morris (PM) to trim 2019 earnings view. It now expects earnings of $4.53.
HubSpot (HUBS) Gears Up for Q3 Earnings: What's in Store?
by Zacks Equity Research
HubSpot's (HUBS) third-quarter performance is likely to have benefited from well defined-diversified subscription services at different user levels for its CRM, Sales Hub, Service Hub and Marketing Hub offerings.
Altria's (MO) Q3 Earnings & Revenues Up Y/Y on Solid Pricing
by Zacks Equity Research
Altria's (MO) performance in third-quarter 2019 gains from improved top-line performance, mainly driven by better pricing.
Altria (MO) Q3 Earnings Miss Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of -5.26% and 2.49%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Seagate (STX) Gears Up for Q1 Earnings: What's in Store?
by Zacks Equity Research
Seagate's (STX) sustained focus on launching storage products is a positive in the to-be-reported quarter.
Factors Likely to Decide Newell's (NWL) Fate in Q3 Earnings
by Zacks Equity Research
Newell's (NWL) third-quarter results are expected to reflect gains from innovation, e-commerce and cost savings. However, lower core sales and adverse currency might have been drags.
Why Altria (MO) Might Surprise This Earnings Season
by Zacks Equity Research
Altria (MO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Qorvo (QRVO) Gears Up for Q2 Earnings: What's in Store? (Revised)
by Zacks Equity Research
Qorvo's (QRVO) Q2 results are likely to reflect benefits from robust growth in wireless connectivity and base station solutions as well as expanding portfolio of 5G and GaN solutions.
JUUL Continues to Unravel as Altria's (MO) Q3 Earnings Near
by Christopher Vargas
Altria (MO) is set to report its third quarter results on Thursday, October 31 before the opening bell.